Effect of Three Different Injection Sites on the Pharmacokinetics of the Once-Daily Human GLP-1 Analogue Liraglutide

被引：13
|
作者：
Kapitza, Christoph [1 ]
Zdravkovic, Milan [2 ]
Zijlstra, Eric [1 ]
Segel, Stine [2 ]
Heise, Tim [1 ]
Flint, Anne [2 ]
机构：
[1] Profil Inst Stoffwechselforsch GmbH, D-41460 Neuss, Germany
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 06期
关键词：
Type 2 diabetes mellitus; glucagon-like peptide-1; incretin; exenatide; DPP-IV; GLUCAGON-LIKE PEPTIDE-1; ABSORPTION; INSULIN; NN2211; CELL; PHARMACODYNAMICS; TOLERABILITY; SAFETY;
D O I：
10.1177/0091270010374474
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：951 / 955
页数：5
相关论文
共 50 条
  • [1] The effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide
    Kapitza, Christoph
    Flint, Anne
    Spitzer, Heike
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A593 - A593
  • [2] The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol
    Kapitza, Christoph
    Flint, Anne
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A593 - A593
  • [3] Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
    Russell-Jones, David
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 137 - 140
  • [4] The once-daily human GLP-1 analogue liraglutide decreases postprandial hunger and energy intake
    Flint, Anne
    Kapitza, Christoph
    Hinds-Berger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A165 - A165
  • [5] Mechanism of Protraction for Liraglutide, the Once-Daily Human GLP-1 Analog
    Knudsen, Lotte B.
    Nielsen, Per F.
    Steensgaard, Dorte B.
    Bloch, Paw
    Lau, Jesper
    Agersoe, Henrik
    DIABETES, 2009, 58 : A532 - A532
  • [6] Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
    Vilsboll, Tina
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 231 - 237
  • [7] New Aspects to the Once-Daily GLP-1 Mimetic Liraglutide
    Schneider, S.
    DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (05): : 395 - 402
  • [8] Effects of the once-daily human GLP-1 analogue liraglutide on appetite and energy intake in type 2 diabetes
    Horowitz, M.
    Flint, A.
    Doran, S.
    Rasmussen, M. F.
    Kapitza, C.
    Andreasen, A. H.
    Jones, K. L.
    Zdravkovic, M.
    Chapman, I. M.
    DIABETOLOGIA, 2008, 51 : S355 - S355
  • [9] The Pharmacokinetics, Pharmacodynamics, and Tolerability of Liraglutide, a Once-Daily Human GLP-1 Analogue, After Multiple Subcutaneous Administration in Healthy Chinese Male Subjects
    Jiang, Ji
    Zhang, Jianyan
    Jacobsen, Lisbeth V.
    Hu, Pei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (12): : 1620 - 1627
  • [10] The molecular basis for the delayed absorption of the once-daily human GLP-1 analoge, liraglutide
    Steensgaard, Dorte B.
    Thomsen, Jens K.
    Olsen, Helle B.
    Knudsen, Lotte B.
    DIABETES, 2008, 57 : A164 - A164
12345